These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 4391432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW.
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V.
    Med Pharmacol Exp Int J Exp Med; 1967 Jul; 16(2):142-6. PubMed ID: 5298397
    [No Abstract] [Full Text] [Related]

  • 5. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z, Kraus P.
    Act Nerv Super (Praha); 1968 Oct 03; 10(3):331. PubMed ID: 4387433
    [No Abstract] [Full Text] [Related]

  • 6. [New data on monoamine oxidase inhibitors].
    Gorkin VZ.
    Vestn Akad Med Nauk SSSR; 1971 Oct 03; 26(11):23-8. PubMed ID: 4942003
    [No Abstract] [Full Text] [Related]

  • 7. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW, Roush BW.
    Arch Int Pharmacodyn Ther; 1972 Aug 03; 198(2):270-6. PubMed ID: 5054735
    [No Abstract] [Full Text] [Related]

  • 8. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L.
    J Pharmacol Exp Ther; 1967 Jul 03; 157(1):81-8. PubMed ID: 6029494
    [No Abstract] [Full Text] [Related]

  • 9. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G, Quiring K, Palm D.
    Naunyn Schmiedebergs Arch Pharmacol; 1972 Jul 03; 273(1):27-42. PubMed ID: 4260803
    [No Abstract] [Full Text] [Related]

  • 10. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J, Kattau R, Slater IH, Fuller RW.
    J Med Chem; 1968 Jan 03; 11(1):95-7. PubMed ID: 4384132
    [No Abstract] [Full Text] [Related]

  • 11. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin].
    Gorkin VZ, Tat'ianenko LV, Suvorov NN, Nekliudov AD.
    Biokhimiia; 1967 Jan 03; 32(5):1036-46. PubMed ID: 5599890
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F, Youdim MB, Agid Y, Glowinski J.
    J Neural Transm; 1973 Jan 03; 34(4):279-89. PubMed ID: 4149516
    [No Abstract] [Full Text] [Related]

  • 14. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.
    Bartonícek VJ.
    Pharmacology; 1970 Jan 03; 4(1):16-24. PubMed ID: 4393462
    [No Abstract] [Full Text] [Related]

  • 15. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS, Lovenberg W, Keiser H, Sjoerdsma A.
    Biochem Pharmacol; 1968 Jan 03; 17(1):109-19. PubMed ID: 4384242
    [No Abstract] [Full Text] [Related]

  • 16. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M, Semmel M, Schor JM.
    Enzymologia; 1968 Jul 15; 34(5):299-303. PubMed ID: 5672567
    [No Abstract] [Full Text] [Related]

  • 17. [Studies on the monoamine oxidase inhibiting properties of imidazole derivatives].
    Winter R.
    Acta Biol Med Ger; 1973 Jul 15; 30(4):555-61. PubMed ID: 4146878
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG, Baker RG, Banna NR.
    J Pharmacol Exp Ther; 1967 Dec 15; 158(3):405-15. PubMed ID: 5299660
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
    Popov N, Lietz W, Matthies H.
    Acta Biol Med Ger; 1967 Dec 15; 18(2):233-44. PubMed ID: 5586804
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.